Physician profile
Timothy Leach
NPI 1356429534
$3,261.79
in general payments reported to CMS, 2019-2025
20 companies · $702 in 2025
The $702 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $46.91 · 2021: $160 · 2022: $227 · 2023: $631 · 2024: $439 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726 · Education: $45.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.48 |
| Education | $45.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $533.62 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $398.89 | 2022-2025 | Bijuva |
| Abbvie INC. | $357.23 | 2019-2023 | |
| Intuitive Surgical, INC. | $250.79 | 2019 | |
| Pfizer INC. | $244.00 | 2021-2025 | |
| Therapeuticsmd, INC. | $225.76 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $179.97 | 2019 | |
| Exeltis, USA INC. | $170.91 | 2023-2025 | Slynd, Twirla, Tyblume |
| Evofem Biosciences, INC. | $162.91 | 2024-2025 | Phexxi, Solosec, Phexx |
| Prescient Surgical | $148.75 | 2019 | |
| Amag Pharmaceuticals, INC. | $125.00 | 2019 | |
| Organon LLC | $98.84 | 2022-2024 | Nexplanon |
| Daiichi Sankyo INC. | $97.14 | 2022-2024 | Injectafer |
| Focal Therapeutics, INC. | $92.16 | 2019 | |
| Myriad Women'S Health, INC. | $48.08 | 2023 | Myrisk |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $44.38 | 2021-2023 | Coolseal Generator |
| Millicent US INC | $26.70 | 2024 | |
| Biogen, INC. | $25.85 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $18.49 | 2021 | |
| Coopersurgical, INC. | $12.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.